A Multicenter Prospective Phase Ii Trial Of Neo-Adjuvant (Fec 100)/Cisplatin-Docetaxel With Or Without Trastuzumab In Locally Advanced Breast Cancer. Gulf Oncology Research Group (Gorg-001)
CANCER RESEARCH(2010)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要